Non-Interventional Research U.S. and Puerto Rico Investigators

Bristol-Myers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support our medical plans in the following therapeutic areas: cardiovascular/metabolics, neuroscience, cancer, immunology and virology.

Objectives

The Bristol-Myers Squibb ISR application process provides a framework and allows investigators to work from a common set of criteria, requirements and schedule of events. The process is designed to ensure scientific rigor and patient safety while supporting unique research ideas and providing insights into areas of unmet medical need.

Bristol-Myers Squibb will be accepting research proposals/applications beginning April 15, 2012 through midnight June 30, 2012. It is imperative that your application is received on or before June 30, 2012, to ensure that it is considered during the established review cycle. An internal Scientific Research committee will be assessing all submitted applications with the intent of conveying the committee’s decision by August 15, 2012.

Disclaimer

Requests for Research Proposals are not to be interpreted as suggesting that any product is safe or effective for an investigational use or recommended for any use outside of its approved labeling. Bristol-Myers Squibb does not guarantee support. Please note that studies may be submitted for “drug-only” support as well as drug & funding support. Support is solely recognized at the time of full execution of the clinical research agreement.


Therapeutic Area Products
Cardiovascular/Metabolics ONGLYZA™ (saxagliptin) Partnered with AstraZeneca
PLAVIX® (clopidogrel bisulfate) Partnered with Sanofi-aventis
Please note that PLAVIX® (clopidogrel bisulfate) and ONGLYZA™ (saxagliptin) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here.
Immunoscience Belatacept
ORENCIA® (abatacept)
Please note that Belatacept and ORENCIA® (abatacept) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here.
Neuroscience ABILIFY® (aripiprazole) Partnered with Otsuka Pharmaceutical Co., Ltd.
Please note that ABILIFY® (aripiprazole) does not have any research proposals posted at this time, however, you may submit your research concept by clicking here.
Oncology ERBITUX® (cetuximab) Partnered with Eli Lilly
Ipilimumab
IXEMPRA® (ixabepilone)
SPRYCEL® (dasatinib)
Please note that ERBITUX® (cetuximab), Ipilimumab, IXEMPRA® (ixabepilone) and SPRYCEL® (dasatinib) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here.
Virology ATRIPLA® (efavirenz / emtricitabine / tenofovir disoproxil fumarate) Partnered with Gilead
REYATAZ® (atazanavir sulfate)
SUSTIVA® (efavirenz)
BARACLUDE® (entecavir)

Click here for trademark information on Bristol-Myers Squibb products.

Please click here to agree and return to a saved application.

Please research questions, please click here.